Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Phosphoinositide 3-kinases (PI3Ks) play important role in Non-Small Cell Lung Cancer. PI3Ks constitute a lipid kinase family which modulates the function of numerous substrates involved in the regulation of cell survival, cell cycle progression and cellular growth. Herein, we describe the ligand based pharmacophore combined with molecular docking studies methods to identify new potent PI3K inhibitors. Several pharmacophore models were generated and validated by Guner-Henry scoring Method. The best models were utilized as 3D pharmacophore query to screen against ZINC database (Chemical and Natural) and the retrieved hits were further validated by fitness score, Lipinski's rule of five. Finally four compounds were found to have good potential and they may act as novel lead compounds for PI3K inhibitor designing.
Introduction
Phosphoinositide 3-kinases (PI3Ks) catalyze phosphorylation of the 3-OH group of phosphatidylinositol (PI) to generate phosphatidylinositol 3-phosphate (PIP), phosphatidylinositol 3,4-bisphosphate (PIP2), and phosphatidylinositol 3, 4, 5-trisphosphate (PIP3), which act as second messengers [1] . In the appropriate cellular context, these three lipids can regulate a remarkably diverse array of physiological processes, including cell growth, survival, differentiation, and chemotaxis [2] . There are three classes of PI3Ks-classes I, II and III-based on their sequences and substrate specificities. Class I PI3Ks are further divided into class IA enzymes (PI3Kα, β, and δ), which have a p85 regulatory subunit and three different catalytic subunits (p110α, β, and δ), and a class IB enzyme (PI3Kγ) with a p101 regulatory subunit and p110γ catalytic subunit, which are activated by tyrosine kinases or G protein-coupled receptors to generate PIP3.
Recently, it has been confirmed that angiogenesis, which is essential for tumor growth and metastasis, selectively requires the p110α isoform of PI3K to control endothelial cell migration [3] . All these facts suggest that PI3K p110α is a potential and attractive target for cancer therapy and hence spark great interest in the discovery and development of inhibitors. The aim of this study was to identify new potent inhibitors and to investigate important chemical features responsible for inhibition of PI3K receptor. Studies have suggested that pharmacophore model is widely used to explore the important chemical features and to find new class of chemical entities [4] [5] [6] . Hence in this study, ligand based 3D pharmacophore models were generated and the best hypotheses were selected based on potency validation and Guner-Henry scoring methods. The obtained hits were subsequently filtered by fitness score, Lipinski's rule of five and ADME (Absorption, Distribution, Metabolism and Excretion) properties. Virtual screening was found to be successful method especially when combined with molecular docking studies to eliminate the false positive results. Therefore, molecular docking was performed to identify the binding modes and interaction of the hits in the active site of PI3K.
Material and Methods

Selection of Biological Dataset
A series of 46 compounds consisted of 2-aminothiazole (S)-proline-amide-urea series of selective PI3Kα inhibitors with their biological activities (IC50) were taken from the literature [7] . These molecules have their IC50 values derived from same assay and it ranges between 1.8 and 10004 nM. The given inhibitory concentration values were changed to minus logarithmic scale value of pIC50 (logIC50) to use the biological data for pharmacophore modeling generation. The structures and their corresponding biological activity were shown in Table 1 
Computational Details
The chemical structure of PI3K inhibitors was sketched using sketch molecule function whose partial atomic charge was calculated using GasteigerHuckel method and its energy minimization was performed using Tripos force field in SYBYL. The pharmacophore model generation and screening was performed using Maestro software. Molecular docking was performed using SYBYL-X2.1 package.
Pharmacophore Model Generation
In the absence of macromolecule structure, ligand based pharmacophore modeling is the key computational strategy for facilitating the drug discovery process [8] . Hence, ligand based pharmacophore modeling was carried out for the known 46 PI3K inhibitors using the PHASE module which is the highly flexible system for pharmacophore model generation in Maestro [9] . Initially structures were cleaned and various conformations were generated by using Ligprep module. PHASE provides the set of six pharmacophore features namely, hydrogen bond acceptor (A), hydrogen bond donor (D), hydrophobic (H), aromatic rings (R), negatively ionizable (N) and positively ionizable group (P) for creating the pharmacophore sites. The dataset were distributed as active, inactive, or intermediate based on the biological activity values. Out of 46 compounds, we have set 8 molecules as active (pIC50 > 8.300), 19 as inactive molecules (pIC50 < 7.500), and rest of them as intermediate (neither active nor inactive). Searching for common hypothesis was performed using both five and six pharmacophoric sites. The survival scores (both ''survival'' and ''survival-inactive'') for each hypothesis were calculated with default parameters. Ample differences between these scores for particular hypothesis suggest that the hypothesis can correctly distinguish between active and inactives.
Pharmacophore Validation
Pharmacophore validation was performed to evaluate the accuracy and reliability of the generated models. Two types of validation was performed namely, potency validation and Güner-Henry score validation.
Potency Validation
Potency validation was performed using decoy set to test whether the model is good enough to pick the active compounds. Decoys are the molecules that shows least or negligible interaction with the particular protein. To check the potency of the hypothesis, the dataset con- [10] and 46 known PI3K inhibitors were taken. Check was made to find the number of decoys that were mapped to each hypothesis. The model which picks no or less number of decoys was considered to be best pharmacophore.
Güner-Henry Score Validation
Güner-Henry scoring method is applied for quantification of model selectivity and evaluation of model effectiveness of similarity search. This scoring evokes the actives from a molecule dataset consisting of known active and inactive molecules. This scoring system ranges from 0 to 1, where 0 specifies a null model and 1 specifies an ideal model. The score is expected to be greater than 0.7 [11] . The formulas used for calculating GH score are given below:
Güner-Henry score = where Ha is the number of actives in the hits list (true positives), A is the number of active compounds in the database, Ht is the number of hits retrieved, D is the number of compounds in the database, %A is the percentage of known active compounds obtained from the database, %Y is the percentage of known actives in the hits list, E is the enrichment of the concentration of actives by the model relative to random screening without a pharmacophoric approach. Güner-Henry score is considered as a relevant metric, it take into account both percent yield of actives in a database (%Y) and the percent ratio of actives in the hit list (%A).
Pharmacophore Based Virtual Screening
Pharmacophore based virtual screening is the fastest and accurate techniques and can be efficiently used to identify new leads. The best pharmacophore hypotheses were taken as template for retrieving potent molecules with novel chemical structures and desired chemical features from ZINC natural products and chemical products. The obtained hits were further filtered by applying Lipinski's rule of five, fitness score, ADME properties and molecular docking.
ADME Prediction
Pharmacokinetics and toxicity plays an important role in drug discovery and development because ADME is the major cause of failure of drug candidates. The QikProp program [12] was employed to predict the ADME properties of all retrieved compounds. It can predict physically significant descriptors such as partition coefficient, van der Waals surface, aqueous solubility and pharmaceutically relevant properties for small drug-like molecules. In this work, we considered all the properties predicted by Qikprop such as amine, amidine, acid, amide, rotor, rtvFG, CNS, mol MW, dipole, SASA, FOSA, FISA, PISA, WPSA, volume, donorHB, accptHB, glob, QPpolrz, QPlogPC16, QPlogPoct, QPlogPw, QPlogPo/w, QPlogS, QPlogHERG, QPPCaco, QPlogBB, QPPMDCK, QPlogKp, IP(ev), EA(ev), metab, QPlogKhsa, Human Oral Absorption, SAFluorine, SAamideO, PSA, NandO are within the recommended range. The reason behind considering all these properties is to make sure that whether these particular chosen molecules from database can stand the Lipinski's rule, as well as pharmacokinetics and pharmacodynamics properties.
Molecular Docking
Molecular docking provides visualization of potential binding orientation of the hits with the important residues of PI3K. Docking was performed using Surflexdock interfaced with SYBYLX2.0.
[13] The Surflex dock uses an empirically derived scoring function that is based on the binding affinities of the protein ligand complexes. The protein was prepared using structure preparation tool and energy minimizationwas performed for 100 steps utilizing Powell method and Tripos force field. The binding site residues were used for generation of protomol. Protomolrepresents the unique and important factor of the docking algorithm, representing the interaction of the ligand with the binding site of the protein. It implements the Hammerhead's empirical scoring function with the molecular similarity method to create putative poses of ligand fragments. The Surflex scoring function which is based on the binding affinities of protein ligand complexes takes into account several terms, including hydrophobic, polar, repulsive, entropic and solvation. The docking scores are expressed in terms of -lg10Kd units to evaluate the docking results, where Kd represents a dissociation constant of a ligand.
Results and Discussion
Pharmacophore Model Generation
To find the common pharmacophore model, the set of 46 known PI3K inhibitors were divided into active, inactive and intermediate molecules on the basis of their activity values (pIC50) i.e. molecules with pIC50 > 8.300 considered as active (8 molecules) and those with pIC50 < 7.500 was considered as inactive (19 molecules), whereas those in between were considered as intermediates (36 molecules). Pharmacophore hypotheses were generated using five and six pharmacophoric sites. A total of 678 hypotheses with five pharmacophoric sites and 348 hypotheses with six pharmacophoric sites were identified. The survival scores for the generated hypotheses range from 2.474 to 3.713. The obtained hypotheses were redundant and had same combination of pharmacophoric sites. Therefore, we set A-acceptor, D-donor, H-hydrophobic, P-positives, N-negatives, R-aromatic ring.
The bold values indicate the selected hypothesis. Survival score: weighted combination of the vector, site, volume, and survival scores, and a term for the number of matches and the minimum value of this score is 1.0, Survival-inactive-survival score: for actives with a multiple of the survival score for inactives subtracted, Post-hoc: This score is the result of rescoring, and is a weighted combination of the vector, site, volume, and selectivity scores, Site: measures how closely the site points are superimposed in an alignment to the pharmacophore of the structures that contribute to this hypothesis, based on the RMS deviation of the site points of a ligand from those of the reference ligand, Vector: measures how well the vectors for acceptors, donors, and aromatic rings are aligned in the structures that contribute to this hypothesis, Volume: Measures how much the volumes of the contributing structures overlap when aligned on the pharmacophore, Selectivity: The selectivity is the negative logarithm of the fraction of molecules in the Index that match the hypothesis. A selectivity of 2 means that 1 in 100 molecules match. High selectivity means that the hypothesis is more likely to be unique to the actives, Energy: relative energy of the reference ligand in kcal/mol. This is the energy of the reference conformation relative to the lowest-energy conformation, Activity: Activity of the reference ligand, Inactive: Survival score of inactives.
survival score as filtering criteria with the objective of selecting only top ten ranked hypotheses with nonredundant survival scores using both five and six pharmacophoric sites. The selected twenty one pharmacophore hypotheses along with its survival scores are tabulated in Table 2 .
Potency Validation
A database comprising of 1047 molecules (1000 decoys and 46 known PI3K inhibitors) were used for potency validation. Potency validation was performed to check which pharmacophore model was able to pick more active inhibitors with less number of decoys. Among the selected twenty one hypotheses, we found the hypotheses DDHHR has picked 26 actives with 12 decoys which indicates these two pharmacophore models are more reliable in picking the active molecules.
Güner-Henry Scoring
From the results of potency validation, Güner-Henry scores were calculated for all twenty one pharmacophore hypothesis and tabulated in Table 3 . The pharmacophore model with GH score in the range of 0.6 to 1.0 is believed to be a good model. The two pharmacophore hypothesis DDHHR is showing higher GH score than others and hence, these pharmacophore hypotheses were selected and used for screening. The selected pharmacophore hypothesis DDHHR is represented in Fig.  1(a) and (b) .
Pharmacophore Based Virtual Screening
The selected pharmacophore hypothesis DDHHR was employed as 3D query against ZINC Chemical and Natural compounds. Compounds whose chemical group maps with the pharmacophore sites were captured as The bold values indicate the goodness of the hypothesis based on Guner-Henry score.
Ha is the number of actives in the hits list (true positives), Ht is the number of hits retrieved. A is the number of active compounds in the database, D is the number of compounds in the database, %A is the percentage of known active compounds obtained from the database. %Y is the percentage of known actives in the hits list, E is the enrichment of the concentration of actives by the model relative to random screening without a pharmacophoric approach. GH score of 0.6 to 1 indicates a very good model.
hits. We found out 16046 hits matching DDHHR hypothesis. We chose only the hits which attained the fitness score greater than or equal to 1.5 because the fitness score describes how well the pharmacophore site points align to the hypothesis. A total of 39 hits having fitness score greater than or equal to 1.5 (13 hits in chemical and 26 hits in natural compounds) were obtained and these hits were subjected to ADME prediction. The binding and interaction of compound 36 and the four hits which have the highest activity were illustrated in Fig. 2 .
ADME Prediction
Drug likeness property is an important component for selecting the compound for in vitro studies. So, we investigated the drug likeliness of 2548 hits by using Qikprop module. The recommended ranges are calculated on the basis of molecular characteristics of a particular compound as well as pharmacokinetic and pharmacodynamics behavior of a molecule from invitro and in-vivo studies. The hits which follow Lipinski's rule and other ADME properties were alone selected which in turn gave 39 hits. The hits were checked for structural redundancy and duplicate structures were eliminated which yielded 24 hits whose binding interactions were studied using docking.
Molecular Docking
To study the binding mode of the obtained hits with PI3K, we performed molecular docking using Surflex dock to find the suitable orientation of the hits within the binding site. We also characterized the binding site of PI3K which comprises of the following residues HIS39, PHE87, PHE88, PHE111 , PHE112, ASN114,  MET115, PHE116, TYR166, ARG170, TYR184,  ASP185, VAL186, LEU187, GLN203, LEU206,  LYS210, PHE211, TRP259, GLY260, TYR262,  HIS263, PHE265, SER266, LEU267, GLU269,  ALA270, TRP283, LEU286, PRO287, PHE288,  VAL289, THR290 , SER291, LEU292, ALA293 and PHE294. The structure of PI3K was prepared using Structure preparation tool and hits obtained from screening was prepared using Ligand preparation tool in SYBYL. The Surflex score: Total Surflex Dock score expressed as elog(Kd), Crash score: The degree of inappropriate penetration by the ligand into the protein, Polar score: Contributions of hydrogen bonding and salt bridge interactions to the total score. mol MW: Molecular weight of the molecule, accptHB: Estimated number of hydrogen bonds that would be accepted by the solute from water molecules in an aqueous solution, DonorHB: estimated number of hydrogen bonds that would be donated by the solute to water molecules in an aqueous solution, QPlogBB: predicted brain/blood partition coefficient, QPlogS: predicted aqueous solubility, log S. S in mol dm_3 is the concentration of the solute in a saturated solution that is in equilibrium with the crystalline solid, QPlogPw: predicted water/gas partition coefficient, QPlogPo/w: Predicted octanol/water partition coefficient, Values in the brackets represent the recommended range of statistical values of respective property.
binding site residues were used for protomol generation. In order to validate the docking results known PI3K inhibitors was also docked into binding site of the receptor using Surflex dock program. After running surflex dock the scores of the active docked conformers were ranked in the molecular spreadsheet. SurflexDock results mainly contain 3 information, (a) total score (surflex score) which is the total SurflexDock score expressed as log (Kd) to represent binding affinities which include hydrophobic, polar, repulsive, entropic and solvation, (b) Crash value which is the degree of inappropriate penetration by the ligand into the protein and of interpenetration between ligand atoms (selfclash) that are separated by rotatable bonds, (c) Polar value is a contribution of the hydrogen bonding and salt bridge interactions to the total score. The surflex score of known inhibitors were >5 and H-bond interaction were found with crucial binding site residues ASN185, TYR166, GLN203, LYS210, TYR262, GLU269 and THR290. Focusing on surflex score and interaction of hits similar to known inhibitors, twenty eight molecules were selected. The scores obtained for these twenty four molecules are tabulated in Table 4 and its associated ADME predictions are shown in Table 5 .
Conclusion
In this study, we described the strategy for identifying new inhibitors for PI3K using combined pharmacophore based virtual screening and docking. The best pharmacophore was generated and validated through GunerHenry scoring method and it was used as query to perform virtual screening against ZINC database (Chemical and natural). Hits retrieved were filtered on the criterion of fitness score and ADME properties to investigate the reliability of the chosen compounds. Molec- ular docking was performed to improve the accuracy of screening and to find the interaction of the hits. Finally, four compounds were found to have best inhibitory activity. Further studies on these compounds may lead to development of a potent drug to treat diseases related to Non-small cell lung cancer.
